- Home
- CABA vs TSQ Comparison
CABA vs TSQ Comparison
Compare CABA & TSQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CABA
- TSQ
- Stock Information
- Founded
- CABA 2017
- TSQ 1996
- Country
- CABA United States
- TSQ United States
- Employees
- CABA N/A
- TSQ N/A
- Industry
- CABA Biotechnology: Biological Products (No Diagnostic Substances)
- TSQ Broadcasting
- Sector
- CABA Health Care
- TSQ Consumer Discretionary
- Exchange
- CABA Nasdaq
- TSQ Nasdaq
- Market Cap
- CABA 118.8M
- TSQ 101.3M
- IPO Year
- CABA 2019
- TSQ 2000
- Fundamental
- Price
- CABA $1.21
- TSQ $7.10
- Analyst Decision
- CABA Strong Buy
- TSQ Buy
- Analyst Count
- CABA 8
- TSQ 1
- Target Price
- CABA $21.00
- TSQ $15.00
- AVG Volume (30 Days)
- CABA 652.6K
- TSQ 62.4K
- Earning Date
- CABA 05-19-2025
- TSQ 05-08-2025
- Dividend Yield
- CABA N/A
- TSQ 11.70%
- EPS Growth
- CABA N/A
- TSQ N/A
- EPS
- CABA N/A
- TSQ N/A
- Revenue
- CABA N/A
- TSQ $450,024,000.00
- Revenue This Year
- CABA N/A
- TSQ N/A
- Revenue Next Year
- CABA N/A
- TSQ $6.71
- P/E Ratio
- CABA N/A
- TSQ N/A
- Revenue Growth
- CABA N/A
- TSQ N/A
- 52 Week Low
- CABA $0.99
- TSQ $6.47
- 52 Week High
- CABA $13.50
- TSQ $12.74
- Technical
- Relative Strength Index (RSI)
- CABA 44.50
- TSQ 50.04
- Support Level
- CABA $1.23
- TSQ $6.73
- Resistance Level
- CABA $1.41
- TSQ $7.09
- Average True Range (ATR)
- CABA 0.11
- TSQ 0.27
- MACD
- CABA 0.02
- TSQ 0.08
- Stochastic Oscillator
- CABA 39.39
- TSQ 61.76
About CABA Cabaletta Bio Inc.
Cabaletta Bio Inc is a clinical-stage biotechnology company focused on the discovery and development of engineered T cell therapies, and exploring their potential to provide a deep and durable, perhaps curative, treatment, for patients with B cell-mediated autoimmune diseases. Its proprietary technology utilizes Chimeric AutoAntibody Receptor, or CAART cells that are designed to selectively bind and eliminate only specific B cells that produce disease-causing autoantibodies, or pathogenic B cells, while sparing normal B cells. Its CABA platform encompasses two strategies CARTA (chimeric antigen receptor T cells for autoimmunity) and CAART (chimeric autoantibody T cells) has the potential to be applied across a broad range of autoimmune diseases.
About TSQ Townsquare Media Inc.
Townsquare Media Inc is a radio, digital media, entertainment, and digital marketing solutions company principally focused on being the premier local advertising and marketing solutions platform in small and mid-sized markets across the United States. It has three segments which are Subscription Digital Marketing Solutions, Digital Advertising, and Broadcast Advertising. It earns the majority of the revenue from the Broadcasting Advertising segment, which includes its local, regional, and national advertising products and solutions delivered via terrestrial radio broadcast. Its portfolio includes local media brands such as WYRK.com, WJON.com, and NJ101.5.com, and premier national music brands such as XXLmag.com, TasteofCountry.com, UltimateClassicRock.com, and Loudwire.com.